| A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants (NCT02447432) | GlaxoSmithKline | 2015-06-11 |
| Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine (NCT02270944) | GlaxoSmithKline | 2014-11-20 |
| Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. (NCT02838407) | GlaxoSmithKline | 2013-09-23 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection (NCT01746108) | GlaxoSmithKline | 2013-06-18 |
| Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama (NCT01793857) | GlaxoSmithKline | 2013-03-01 |
| Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey (NCT01031329) | GlaxoSmithKline | 2012-11-01 |
| Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children (NCT01160055) | GlaxoSmithKline | 2012-10-01 |
| Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ (NCT01641133) | GlaxoSmithKline | 2012-09-04 |
| Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants (NCT01616459) | GlaxoSmithKline | 2012-07-11 |
| Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children (NCT01545375) | GlaxoSmithKline | 2012-05-21 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers (NCT01485406) | GlaxoSmithKline | 2011-12-12 |
| Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A (NCT01175083) | GlaxoSmithKline | 2011-06-01 |
| Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam (NCT01153841) | GlaxoSmithKline | 2011-02-17 |
| Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea (NCT01248988) | GlaxoSmithKline | 2010-12-01 |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment (NCT01235949) | GlaxoSmithKline | 2010-11-12 |
| Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria (NCT01153893) | GlaxoSmithKline | 2010-10-04 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants (NCT01204658) | GlaxoSmithKline | 2010-09-27 |
| Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose (NCT01119625) | GlaxoSmithKline | 2010-07-12 |
| Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines (NCT01046097) | GlaxoSmithKline | 2010-05-01 |
| Booster and Catch-up Vaccination With Vaccine GSK1024850A (NCT01030822) | GlaxoSmithKline | 2010-04-02 |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children (NCT01027845) | GlaxoSmithKline | 2009-12-08 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination (NCT00985751) | GlaxoSmithKline | 2009-11-24 |
| Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali (NCT00985465) | GlaxoSmithKline | 2009-11-12 |
| Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children (NCT00950833) | GlaxoSmithKline | 2009-08-10 |
| Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ (NCT00907777) | GlaxoSmithKline | 2009-06-23 |
| Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine (NCT00911144) | GlaxoSmithKline | 2009-06-11 |
| Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults (NCT00896064) | GlaxoSmithKline | 2009-05-18 |
| Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease (NCT00861380) | GlaxoSmithKline | 2009-05-04 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age (NCT00814710) | GlaxoSmithKline | 2009-03-07 |
| Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A (NCT00839254) | GlaxoSmithKline | 2009-02-18 |
| Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. (NCT00829010) | GlaxoSmithKline | 2009-02-17 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age (NCT00808444) | GlaxoSmithKline | 2009-01-05 |
| Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A (NCT00792909) | GlaxoSmithKline | 2008-12-02 |
| Evaluation of Pneumococcal Vaccine Formulations in Elderly (NCT00756067) | GlaxoSmithKline | 2008-09-19 |
| Evaluation of Pneumococcal Vaccine Formulations in Young Adults (NCT00707798) | GlaxoSmithKline | 2008-06-30 |
| Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ (NCT00680914) | GlaxoSmithKline | 2008-06-10 |
| Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib (NCT00652951) | GlaxoSmithKline | 2008-04-01 |
| A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays (NCT00637351) | GlaxoSmithKline | 2008-03-01 |
| Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. (NCT00609492) | GlaxoSmithKline | 2008-01-03 |
| Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines (NCT00547248) | GlaxoSmithKline | 2007-10-22 |
| Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae (NCT00523770) | GlaxoSmithKline | 2007-09-01 |
| Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule (NCT00513409) | GlaxoSmithKline | 2007-08-22 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age (NCT00489554) | GlaxoSmithKline | 2007-07-03 |
| Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A (NCT00496015) | GlaxoSmithKline | 2007-07-02 |
| Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants (NCT00390910) | GlaxoSmithKline | 2006-10-01 |
| Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. (NCT00370396) | GlaxoSmithKline | 2006-09-25 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine (NCT00345358) | GlaxoSmithKline | 2006-09-18 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine (NCT00344318) | GlaxoSmithKline | 2006-08-07 |
| Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. (NCT00333450) | GlaxoSmithKline | 2006-08-01 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. (NCT00334334) | GlaxoSmithKline | 2006-06-01 |
| Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population (NCT00327665) | GlaxoSmithKline | 2006-05-01 |
| Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule (NCT00307034) | GlaxoSmithKline | 2006-01-01 |
| A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study (NCT00307554) | GlaxoSmithKline | 2005-11-01 |
| Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine (NCT00307541) | GlaxoSmithKline | 2005-10-27 |